Skip to Content
COVID-19 Resources
Contact DCTD
Show menu
Search this site
Last Updated: 05/04/2021

Funding Opportunity Announcements (FOAs)

Funding Opportunities through DCTD’s Programs

Visit the websites of DCTD's individual programs for more information on currently available funding opportunities.

Trans-DCTD Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed) RFA-CA-21-023 May 30, 2021 July 1, 2021 U24
Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed) RFA-CA-21-024 May 30, 2021 July 1, 2021 U24
Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed) RFA-CA-21-025 June 30, 2021 July 31,2021 U01
NCI Clinical and Translational Exploratory/Developmental Studies (Clinical Trial Optional) PAR-20-292 September 20, 2020 July 21, 2022 R21
DCTD-related Trans-NCI Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (Clinical Trial Optional) PAR-18-841 October 19, 2018 June 15, 2021 U24
Revision Applications for Mechanisms of Cancer Drug Resistance (Clinical Trial Not Allowed) RFA-CA-19-049
RFA-CA-19-050
RFA-CA-19-051
RFA-CA-19-052
RFA-CA-19-053
September 24, 2019 June 24, 2021 R01
U01
U54
P01
P50
3D Technologies to Accelerate HTAN Atlas Building Efforts (Clinical Trial Not Allowed) FRA-CA-21-037 May 30, 2021 November 23, 2021 UH2
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (Clinical Trial Not Allowed) PAR-19-361 October 12, 2019 March 12, 2022 U01
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-193 May 16, 2019 May 8, 2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-194 May 16, 2019 May 8, 2022 R21
Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants (Clinical Trial Not Allowed) PAR-20-074 January 28,
2020
October 29,
2022
R01
DCTD-related Trans-NIH Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (Clinical Trial Optional) PA-18-902 September 5,
2018
September 8,
2021
R01
Bioengineering Research Grants (BRG) (Clinical Trial Not Allowed) PAR-19-158 January 8,
2019
January 8,
2022
R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Not Allowed) PAR-19-149 January 16,
2019
January 8,
2022
R21
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Optional) PAR-19-150 January 16,
2019
January 8,
2022
R21
Mechanisms and Consequences of Sleep Disparities in the U.S. (Clinical Trial Not Allowed) PAR-20-164 June 12, 2020 July 15, 2022 R01
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (Clinical Trial Not Allowed) PAR-19-375 January 16, 2020 January 8, 2023 R03
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (Clinical Trial Not Allowed) PAR-21-166 May 5,2021 January 8, 2024 R01